(ANIX) is set to present final Phase 1 clinical trial results for its breast cancer vaccine at the 2025 San Antonio Breast Cancer Symposium (SABCS) on ...
News
- Is Anixa's First-In-Human Vaccine Poised For Regulatory Momentum? - RTTNews
- CPS Energy is the Host Utility for POWERGEN's Global 2026 Conference in San Antonio, Texas
Biotechnology · Clinical Trials & Medical Discoveries · Dentistry · FDA ... San Antonio, Texas. The purpose of POWERGEN is to shape the future of ...
- bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct ... - Nasdaq
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW), a biotechnology company focused on the need for noninvasive ...
- bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing ...
SAN ANTONIO--(BUSINESS WIRE)--Oct 9, 2025--. bioAffinity Technologies, Inc.(NASDAQ: BIAF, BIAFW) a biotechnology company focused on the need for ...
- Making sense of the 'senseless' after a breakthrough in Austin's yogurt shop murder case
Bioscience-Medicine · Border & Immigration · Economy & Labor · Criminal ... San Antonio City Hall and other downtown buildings usually lit up to ...